PLANTAR FASCIITIS TREATMENT WITH PLATELET-RICH PLASMA INJECTION VERSUS STEROID INJECTION
DOI:
https://doi.org/10.22159/ajpcr.2022.v15i10.46342Keywords:
Plantar fascia, Platelet-rich plasma, Steroid injection, Visual analog scale score, Numerical pain score scoreAbstract
Objective: Plantar fasciitis is characterized by heel pain that worsens when you bear weight after a long period of rest. Injections of steroids are one of the numerous therapeutic techniques that are frequently used to control plantar fasciitis. Numerous studies demonstrate that short-term pain alleviation with steroid injections is not long-lasting. According to recent studies, autologous platelet-rich plasma (PRP) injections encourage healing, which improves both short- and long-term pain alleviation. To compare the effects of local PRP injection and corticosteroid in the management of chronic plantar fasciitis, the current study was conducted.
Methods: Sixty patients who met the criteria for this prospective double-blind trial were randomly assigned to one of two groups. Patients in Group I received an injection of steroid, whereas those in Group II received an injection of PRPs. The PNS numerical pain score (NPS) and a visual analog scale (VAS) were used to evaluate the patients. An evaluation was conducted before the injection as well as at 6 weeks, 3 months, and 6 months after the injection.
Results: The mean VAS in Group I reduced from 7.00 before injection to 2.31 and that in Group II decreased from 7.81 before injection to 1.12. At the 6-month follow-up, the mean NPS score in Group I increased from 7.05 to 1.41 and in Group II from 7.86 to 1.02. The VAS and NPS improvements were statistically significant. In both groups, the plantar fascia thickness had decreased at the conclusion of the 6-month follow-up period (5.88 mm in Group I to 4.03 mm and 5.96 mm to 3.27mm in Group II), and the difference was statistically significant.
Conclusion: When compared to steroid injection, local PRP injection is an excellent therapeutic option for persistent plantar fasciitis with long-lasting positive effects.
Downloads
References
Cornwall MW, McPoil TG. Plantar fasciitis: Etiology and treatment. J Ortho Sports Phys Ther 1999;29:756-60.
Young CC, Rutherford DS, Niedfelt MW. Treatment of plantar fasciitis. Am Fam Physician 2001;63:467-74, 477-8.
Wolgin M, Cook C, Graham C, Mauldin D. Conservative treatment of plantar heel pain: Long-term follow-up. Foot Ankle Int 1994;15:97-102.
Crawford F, Thomson C. Interventions for treating plantar heel pain. Cochrane Database Syst Rev 2003;20:CD000416.
Yang WY, Han YH, Cao XW, Pan JK, Zeng LF, Lin JT, et al. Platelet-rich plasma as a treatment for plantar fasciitis: A meta-analysis of randomized controlled trials. Medicine (Baltimore) 2017;96:e8475.
Barrett SL, Erredge SE. Growth factors for chronic plantar fasciitis? Conference highlights from 2022 western foot and Ankle conference Podiatry today. Healthcare Made Pract 2004;17;36-42.
Vahdatpour B, Kianimehr L, Moradi A, Haghighat S. Beneficial effects of platelet-rich plasma on improvement of pain severity and physical disability in patients with plantar fasciitis: A randomized trial. Adv Biomed Res 2016;28:179.
Bendinelli P, Matteucci E, Dogliotti G, Corsi MM, Banfi G, Maroni P, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-κB inhibition via HGF. J Cell Physiol 2010;225:757-66.
Lee TG, Ahmad TS. Intra lesional autologous blood injection compared to corticosteroid injection for treatment of chronic plantar fasciitis: A prospective, randomized, controlled trial. Foot Ankle Int 2007;28:984-90.
Monto RR. Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis. Foot Ankle Int 2014;35:313-8.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Suman Jain, Dr Vasu srivastava, Dr Vishwas, Dr Rahul Rathi1, Dr LN Meena, Dr B L Kumar
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.